Literature DB >> 32702289

One Two Punch: Combination Chemotherapy Knocks Out Pancreatic Cancer.

Audrey Lumeau1, Pierre Cordelier2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32702289      PMCID： PMC7403455          DOI： 10.1016/j.ymthe.2020.07.014

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

2.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

3.  First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.

Authors:  Louis Buscail; Barbara Bournet; Fabienne Vernejoul; Gilles Cambois; Hubert Lulka; Naïma Hanoun; Marlène Dufresne; Aline Meulle; Alix Vignolle-Vidoni; Laetitia Ligat; Nathalie Saint-Laurent; Frédéric Pont; Sébastien Dejean; Marion Gayral; Frédéric Martins; Jérôme Torrisani; Odile Barbey; Fabian Gross; Rosine Guimbaud; Philippe Otal; Frédéric Lopez; Gérard Tiraby; Pierre Cordelier
Journal:  Mol Ther       Date:  2015-01-14       Impact factor: 11.454

4.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Authors:  Paolo P Provenzano; Carlos Cuevas; Amy E Chang; Vikas K Goel; Daniel D Von Hoff; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

5.  Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.

Authors:  Raphaël Maréchal; Jean-Baptiste Bachet; John R Mackey; Cécile Dalban; Pieter Demetter; Kathryn Graham; Anne Couvelard; Magali Svrcek; Armelle Bardier-Dupas; Pascal Hammel; Alain Sauvanet; Christophe Louvet; François Paye; Philippe Rougier; Christophe Penna; Thierry André; Charles Dumontet; Carol E Cass; Lars Petter Jordheim; Eva-Laure Matera; Jean Closset; Isabelle Salmon; Jacques Devière; Jean-François Emile; Jean-Luc Van Laethem
Journal:  Gastroenterology       Date:  2012-06-13       Impact factor: 22.682

Review 6.  Therapeutic developments in pancreatic cancer: current and future perspectives.

Authors:  John P Neoptolemos; Jörg Kleeff; Patrick Michl; Eithne Costello; William Greenhalf; Daniel H Palmer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-06       Impact factor: 46.802

7.  Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Authors:  Talia Golan; Pascal Hammel; Michele Reni; Eric Van Cutsem; Teresa Macarulla; Michael J Hall; Joon-Oh Park; Daniel Hochhauser; Dirk Arnold; Do-Youn Oh; Anke Reinacher-Schick; Giampaolo Tortora; Hana Algül; Eileen M O'Reilly; David McGuinness; Karen Y Cui; Katia Schlienger; Gershon Y Locker; Hedy L Kindler
Journal:  N Engl J Med       Date:  2019-06-02       Impact factor: 91.245

8.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

9.  Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines.

Authors:  S H Park; J H Sung; E J Kim; N Chung
Journal:  Braz J Med Biol Res       Date:  2014-12-12       Impact factor: 2.590

Review 10.  The role of stromal cancer-associated fibroblasts in pancreatic cancer.

Authors:  Dagny von Ahrens; Tushar D Bhagat; Deepak Nagrath; Anirban Maitra; Amit Verma
Journal:  J Hematol Oncol       Date:  2017-03-28       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.